questionsmedicales.fr
Environnement et santé publique
Santé publique
Méthodes épidémiologiques
Collecte de données
Registre civil
Mortalité
Mortalité : Questions médicales fréquentes
Termes MeSH sélectionnés :
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Mortalité : Questions médicales les plus fréquentes",
"headline": "Mortalité : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Mortalité : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-06-28",
"dateModified": "2025-03-25",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Mortalité"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Registre civil",
"url": "https://questionsmedicales.fr/mesh/D014798",
"about": {
"@type": "MedicalCondition",
"name": "Registre civil",
"code": {
"@type": "MedicalCode",
"code": "D014798",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N06.850.520.308.985"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Cause de décès",
"alternateName": "Cause of Death",
"url": "https://questionsmedicales.fr/mesh/D002423",
"about": {
"@type": "MedicalCondition",
"name": "Cause de décès",
"code": {
"@type": "MedicalCode",
"code": "D002423",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N06.850.520.308.985.550.250"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Mortalité de l'enfant",
"alternateName": "Child Mortality",
"url": "https://questionsmedicales.fr/mesh/D046688",
"about": {
"@type": "MedicalCondition",
"name": "Mortalité de l'enfant",
"code": {
"@type": "MedicalCode",
"code": "D046688",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N06.850.520.308.985.550.287"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Issue fatale",
"alternateName": "Fatal Outcome",
"url": "https://questionsmedicales.fr/mesh/D017809",
"about": {
"@type": "MedicalCondition",
"name": "Issue fatale",
"code": {
"@type": "MedicalCode",
"code": "D017809",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N06.850.520.308.985.550.325"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Mortalité foetale",
"alternateName": "Fetal Mortality",
"url": "https://questionsmedicales.fr/mesh/D046689",
"about": {
"@type": "MedicalCondition",
"name": "Mortalité foetale",
"code": {
"@type": "MedicalCode",
"code": "D046689",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N06.850.520.308.985.550.362"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Mortalité hospitalière",
"alternateName": "Hospital Mortality",
"url": "https://questionsmedicales.fr/mesh/D017052",
"about": {
"@type": "MedicalCondition",
"name": "Mortalité hospitalière",
"code": {
"@type": "MedicalCode",
"code": "D017052",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N06.850.520.308.985.550.400"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Mortalité infantile",
"alternateName": "Infant Mortality",
"url": "https://questionsmedicales.fr/mesh/D007226",
"about": {
"@type": "MedicalCondition",
"name": "Mortalité infantile",
"code": {
"@type": "MedicalCode",
"code": "D007226",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N06.850.520.308.985.550.475"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Mortalité périnatale",
"alternateName": "Perinatal Mortality",
"url": "https://questionsmedicales.fr/mesh/D054238",
"about": {
"@type": "MedicalCondition",
"name": "Mortalité périnatale",
"code": {
"@type": "MedicalCode",
"code": "D054238",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N06.850.520.308.985.550.475.500"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Mortalité maternelle",
"alternateName": "Maternal Mortality",
"url": "https://questionsmedicales.fr/mesh/D008428",
"about": {
"@type": "MedicalCondition",
"name": "Mortalité maternelle",
"code": {
"@type": "MedicalCode",
"code": "D008428",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N06.850.520.308.985.550.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Mortalité prématurée",
"alternateName": "Mortality, Premature",
"url": "https://questionsmedicales.fr/mesh/D061213",
"about": {
"@type": "MedicalCondition",
"name": "Mortalité prématurée",
"code": {
"@type": "MedicalCode",
"code": "D061213",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N06.850.520.308.985.550.550"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Taux de survie",
"alternateName": "Survival Rate",
"url": "https://questionsmedicales.fr/mesh/D015996",
"about": {
"@type": "MedicalCondition",
"name": "Taux de survie",
"code": {
"@type": "MedicalCode",
"code": "D015996",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N06.850.520.308.985.550.900"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Mortalité",
"alternateName": "Mortality",
"code": {
"@type": "MedicalCode",
"code": "D009026",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Jalemba Aluvaala",
"url": "https://questionsmedicales.fr/author/Jalemba%20Aluvaala",
"affiliation": {
"@type": "Organization",
"name": "Health Services Unit, KEMRI-Wellcome Trust Research Programme, Nairobi, Kenya jaluvaala@kemri-wellcome.org."
}
},
{
"@type": "Person",
"name": "Gary Collins",
"url": "https://questionsmedicales.fr/author/Gary%20Collins",
"affiliation": {
"@type": "Organization",
"name": "Centre for Statistics in Medicine, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, Botnar Research Centre, University of Oxford, Oxford, United Kingdom."
}
},
{
"@type": "Person",
"name": "Mike English",
"url": "https://questionsmedicales.fr/author/Mike%20English",
"affiliation": {
"@type": "Organization",
"name": "Health Services Unit, KEMRI-Wellcome Trust Research Programme, Nairobi, Kenya."
}
},
{
"@type": "Person",
"name": "Luís Portugal",
"url": "https://questionsmedicales.fr/author/Lu%C3%ADs%20Portugal",
"affiliation": {
"@type": "Organization",
"name": "Partner and Managing Director ACTUARIAL Group, PhD Mathematical Sciences, University of Liverpool, Fellow Actuary, IAP (Portugal), England, UK."
}
},
{
"@type": "Person",
"name": "An Jacobs",
"url": "https://questionsmedicales.fr/author/An%20Jacobs",
"affiliation": {
"@type": "Organization",
"name": "Clinical Division and Laboratory of Intensive Care Medicine, Department of Cellular and Molecular Medicine, KU Leuven University Hospital, Leuven, Belgium."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "A case-control study on immunologic markers of patients with vitiligo.",
"datePublished": "2022-10-14",
"url": "https://questionsmedicales.fr/article/36244264",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.biopha.2022.113785"
}
},
{
"@type": "ScholarlyArticle",
"name": "Case-Control Study of Long COVID, Sapporo, Japan.",
"datePublished": "2023-04-12",
"url": "https://questionsmedicales.fr/article/37044126",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3201/eid2905.221349"
}
},
{
"@type": "ScholarlyArticle",
"name": "Endothelium-biomarkers for postthrombotic syndrome: a case-control study.",
"datePublished": "2023-03-29",
"url": "https://questionsmedicales.fr/article/37016998",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1097/MBC.0000000000001192"
}
},
{
"@type": "ScholarlyArticle",
"name": "Risk Factors for Postoperative Pneumonia: A Case-Control Study.",
"datePublished": "2022-07-08",
"url": "https://questionsmedicales.fr/article/35875004",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3389/fpubh.2022.913897"
}
},
{
"@type": "ScholarlyArticle",
"name": "Significance of temperature in antimuscarinic toxicity: a case-control study.",
"datePublished": "2022-06-23",
"url": "https://questionsmedicales.fr/article/35735006",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1080/15563650.2022.2088378"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Environnement et santé publique",
"item": "https://questionsmedicales.fr/mesh/D004778"
},
{
"@type": "ListItem",
"position": 3,
"name": "Santé publique",
"item": "https://questionsmedicales.fr/mesh/D011634"
},
{
"@type": "ListItem",
"position": 4,
"name": "Méthodes épidémiologiques",
"item": "https://questionsmedicales.fr/mesh/D004812"
},
{
"@type": "ListItem",
"position": 5,
"name": "Collecte de données",
"item": "https://questionsmedicales.fr/mesh/D003625"
},
{
"@type": "ListItem",
"position": 6,
"name": "Registre civil",
"item": "https://questionsmedicales.fr/mesh/D014798"
},
{
"@type": "ListItem",
"position": 7,
"name": "Mortalité",
"item": "https://questionsmedicales.fr/mesh/D009026"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Mortalité - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Mortalité",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-08",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Mortalité",
"description": "Comment évaluer la mortalité d'une maladie ?\nQuels outils mesurent la mortalité ?\nQu'est-ce qu'un taux de mortalité standardisé ?\nComment la mortalité infantile est-elle mesurée ?\nQuel rôle joue l'autopsie dans le diagnostic de mortalité ?",
"url": "https://questionsmedicales.fr/mesh/D009026?mesh_terms=Case-Control+Studies&page=3#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Mortalité",
"description": "Quels symptômes précèdent souvent la mortalité ?\nComment les symptômes varient-ils selon les âges ?\nQuels symptômes indiquent une maladie terminale ?\nLes symptômes psychologiques influencent-ils la mortalité ?\nQuels symptômes sont liés à la mortalité par cancer ?",
"url": "https://questionsmedicales.fr/mesh/D009026?mesh_terms=Case-Control+Studies&page=3#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Mortalité",
"description": "Quelles mesures préventives réduisent la mortalité ?\nComment l'alimentation influence-t-elle la mortalité ?\nQuel est l'impact de l'exercice sur la mortalité ?\nLes programmes de santé publique réduisent-ils la mortalité ?\nComment le contrôle du tabagisme affecte-t-il la mortalité ?",
"url": "https://questionsmedicales.fr/mesh/D009026?mesh_terms=Case-Control+Studies&page=3#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Mortalité",
"description": "Quels traitements réduisent la mortalité ?\nComment la vaccination impacte-t-elle la mortalité ?\nQuel est l'impact des soins palliatifs sur la mortalité ?\nLes traitements médicaux influencent-ils la mortalité ?\nQuel rôle joue la réhabilitation dans la mortalité ?",
"url": "https://questionsmedicales.fr/mesh/D009026?mesh_terms=Case-Control+Studies&page=3#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Mortalité",
"description": "Quelles complications augmentent la mortalité ?\nComment les maladies chroniques influencent-elles la mortalité ?\nLes complications postopératoires affectent-elles la mortalité ?\nQuel est l'impact des comorbidités sur la mortalité ?\nLes complications liées au diabète influencent-elles la mortalité ?",
"url": "https://questionsmedicales.fr/mesh/D009026?mesh_terms=Case-Control+Studies&page=3#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Mortalité",
"description": "Quels sont les principaux facteurs de risque de mortalité ?\nComment le statut socio-économique affecte-t-il la mortalité ?\nLe stress influence-t-il la mortalité ?\nLes habitudes alimentaires sont-elles un facteur de risque ?\nQuel rôle joue l'alcool dans la mortalité ?",
"url": "https://questionsmedicales.fr/mesh/D009026?mesh_terms=Case-Control+Studies&page=3#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment évaluer la mortalité d'une maladie ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "On utilise des statistiques de décès et des études épidémiologiques."
}
},
{
"@type": "Question",
"name": "Quels outils mesurent la mortalité ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les registres de décès et les enquêtes de santé publique sont couramment utilisés."
}
},
{
"@type": "Question",
"name": "Qu'est-ce qu'un taux de mortalité standardisé ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "C'est un taux ajusté pour comparer des populations avec des structures d'âge différentes."
}
},
{
"@type": "Question",
"name": "Comment la mortalité infantile est-elle mesurée ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle est calculée par le nombre de décès d'enfants de moins d'un an pour 1 000 naissances."
}
},
{
"@type": "Question",
"name": "Quel rôle joue l'autopsie dans le diagnostic de mortalité ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'autopsie aide à déterminer la cause de décès et à améliorer les statistiques de mortalité."
}
},
{
"@type": "Question",
"name": "Quels symptômes précèdent souvent la mortalité ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes graves comme la détresse respiratoire ou l'insuffisance cardiaque."
}
},
{
"@type": "Question",
"name": "Comment les symptômes varient-ils selon les âges ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes peuvent être plus aigus chez les personnes âgées, augmentant le risque de mortalité."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une maladie terminale ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Fatigue extrême, perte de poids, et douleurs persistantes sont des indicateurs."
}
},
{
"@type": "Question",
"name": "Les symptômes psychologiques influencent-ils la mortalité ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des troubles comme la dépression peuvent augmenter le risque de mortalité."
}
},
{
"@type": "Question",
"name": "Quels symptômes sont liés à la mortalité par cancer ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Perte de poids inexpliquée, douleurs persistantes et fatigue sont fréquents."
}
},
{
"@type": "Question",
"name": "Quelles mesures préventives réduisent la mortalité ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des campagnes de sensibilisation et des dépistages précoces sont efficaces."
}
},
{
"@type": "Question",
"name": "Comment l'alimentation influence-t-elle la mortalité ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation équilibrée peut réduire le risque de maladies chroniques et de mortalité."
}
},
{
"@type": "Question",
"name": "Quel est l'impact de l'exercice sur la mortalité ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'exercice régulier diminue le risque de maladies cardiovasculaires et de mortalité."
}
},
{
"@type": "Question",
"name": "Les programmes de santé publique réduisent-ils la mortalité ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils améliorent l'accès aux soins et sensibilisent aux comportements sains."
}
},
{
"@type": "Question",
"name": "Comment le contrôle du tabagisme affecte-t-il la mortalité ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Réduire le tabagisme diminue le risque de cancers et de maladies respiratoires, abaissant la mortalité."
}
},
{
"@type": "Question",
"name": "Quels traitements réduisent la mortalité ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements précoces et appropriés des maladies chroniques diminuent la mortalité."
}
},
{
"@type": "Question",
"name": "Comment la vaccination impacte-t-elle la mortalité ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les vaccins réduisent la mortalité en prévenant des maladies infectieuses graves."
}
},
{
"@type": "Question",
"name": "Quel est l'impact des soins palliatifs sur la mortalité ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les soins palliatifs améliorent la qualité de vie et peuvent réduire la mortalité chez les patients en phase terminale."
}
},
{
"@type": "Question",
"name": "Les traitements médicaux influencent-ils la mortalité ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des traitements efficaces peuvent prolonger la vie et réduire le risque de décès."
}
},
{
"@type": "Question",
"name": "Quel rôle joue la réhabilitation dans la mortalité ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "La réhabilitation améliore la fonction physique et peut réduire le risque de mortalité."
}
},
{
"@type": "Question",
"name": "Quelles complications augmentent la mortalité ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications comme l'infection ou l'insuffisance organique peuvent accroître le risque de décès."
}
},
{
"@type": "Question",
"name": "Comment les maladies chroniques influencent-elles la mortalité ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles augmentent le risque de complications graves, entraînant une mortalité plus élevée."
}
},
{
"@type": "Question",
"name": "Les complications postopératoires affectent-elles la mortalité ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des complications comme les infections peuvent augmenter le risque de décès après une chirurgie."
}
},
{
"@type": "Question",
"name": "Quel est l'impact des comorbidités sur la mortalité ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les comorbidités augmentent le risque de mortalité en rendant le traitement plus complexe."
}
},
{
"@type": "Question",
"name": "Les complications liées au diabète influencent-elles la mortalité ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des complications comme les maladies cardiovasculaires augmentent le risque de décès."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque de mortalité ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'âge avancé, le tabagisme, l'obésité et les maladies chroniques sont des facteurs clés."
}
},
{
"@type": "Question",
"name": "Comment le statut socio-économique affecte-t-il la mortalité ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un statut socio-économique bas est associé à un risque accru de mortalité."
}
},
{
"@type": "Question",
"name": "Le stress influence-t-il la mortalité ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress chronique peut contribuer à des maladies graves et augmenter le risque de décès."
}
},
{
"@type": "Question",
"name": "Les habitudes alimentaires sont-elles un facteur de risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une mauvaise alimentation peut accroître le risque de maladies et de mortalité."
}
},
{
"@type": "Question",
"name": "Quel rôle joue l'alcool dans la mortalité ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une consommation excessive d'alcool est liée à un risque accru de mortalité par maladies diverses."
}
}
]
}
]
}
Vitiligo is a depigmentation skin disease often coexisting with other autoimmune disorders. The prevalence is 0.5-2 % of the world's population. A combination of genetic, environmental and biochemical...
We conducted a cross-sectional survey among SARS-CoV-2-positive persons and negative controls in Sapporo, Japan, to clarify symptoms of long COVID. We collected responses from 8,018 participants, 3,69...
The postthrombotic syndrome (PTS) is a long-term complication of deep venous thrombosis (DVT). Increase knowledge on the PTS pathophysiology and novel biomarkers are needed in order to predict PTS dev...
A case-control study was conducted. Inclusion criteria were symptomatic and confirmed DVT patients treated with anticoagulants for at least 3 months. Villalta score was performed at the time of inclus...
Thirty two patients and 61 controls were included. PTS patients showed higher levels of CEC (0.56/μl (0.34-1.5) vs. 0.20/μl (0.11-0.77); P = 0.04) and EPC (0.75/μl (0.38-1.52) vs. 0.09/μl (0.05-0.82);...
The formation and early resolution of DVT are characterized by inflammation and endothelial/platelet activation. We have identified possible novel biomarkers such as CEC, EPC and fractalkine for the d...
Postoperative pneumonia is a preventable complication associated with adverse outcomes, that greatly aggravates the medical expenses of patients. The goal of our study is to identify risk factors and ...
A matched 1:1 case-control study, including adult patients who underwent surgery between January 2020 and June 2020, was conducted in the Second Affiliated Hospital of Kunming Medical University in Ch...
Out of 17,190 surgical patients, 264 (1.54%) experienced postoperative pneumonia. Increased age, chronic obstructive pulmonary disease, emergency surgery, postoperative reduced albumin, prolonged vent...
Postoperative pneumonia is associated with severe clinical outcomes. We identified six independent risk factors that can aid in risk stratification and management of patients at risk of postoperative ...
www.chictr.org.cn, identifier: chiCTR2100045986....
Antimuscarinic toxicity can result in temperature dysregulation, but the clinical significance of this is unclear. The objective of this study was to compare peak temperatures between antimuscarinic p...
This was a case-control analysis at two large, urban, academic medical centers from January 1, 2016, through December 31, 2021. We compared peak temperature (...
Fifty-six patients met inclusion criteria of which 23 developed severe outcomes: 16 seizures, 9 cases with hypotension, 5 intubations, and 2 ventricular dysrhythmias. Tmax amongst all patients ranged ...
Maximum temperatures did not differ between patients with and without severe outcomes in the setting of antimuscarinic toxicity, and temperature was poorly predictive of outcomes. Our findings suggest...
Asbestos lung content is regarded as the most reliable tool for causal attribution of malignant mesothelioma (MM) to previous asbestos exposures. However, there is a lack of studies on asbestos burden...
Asbestos lung content has been assessed on formalin-fixed lung fragments using scanning electron microscopy coupled with energy dispersion spectroscopy (SEM-EDS) on individuals deceased from MM (cases...
Asbestos and asbestos bodies (ABs) were found, respectively, in 73.7% and 43.2% of cases and in 28 and 22% of controls; in MM cases the most represented asbestos types were crocidolite and amosite, wh...
The results suggest a correlation between asbestos burden in lungs and MM risk. The different concentration of chrysotile, as well as the different width of asbestos fibers in MM males and females mig...
Psoriasis (PsO) is a chronic inflammatory skin condition, often accompanied by psoriatic arthritis (PsA) and linked to various comorbidities and increased mortality rates. This study aimed to explore ...
Idiopathic intracranial hypertension (IIH) is a condition that mostly affects obese women of childbearing age but has been reported to be temporally related to new diagnoses of anemia. Despite these r...
Consecutive IIH patients were recruited from neuro-ophthalmology clinics and matched by age and sex to consecutive patients attending neuro-ophthalmology clinics with diagnoses other than IIH. Complet...
One hundred twenty-three IIH patients and 113 controls were included in the study. More IIH patients than controls had anemia (22.8%, 28/123 vs 10.6%, 12/113, P = 0.01) with an odds ratio of 2.48 (95%...
Idiopathic intracranial hypertension patients have a higher prevalence of anemia compared with non-IIH neuro-ophthalmology patients. The anemia was mostly mild and may be explained by other factors re...
Adverse drug reactions (ADRs) caused by opioid drugs show individual differences. Our objective was to explore the association between gene polymorphism and ADRs induced by opioid drugs....
Evidence-based medical data analysis was conducted for genes related to ADRs induced by opioid drugs to select target genes. Sixty patients with cancer pain who had ADRs after taking opioid drugs (mor...
Based on a database search and evidence-based medical data, we identified CYP2D6*10, CYP3A5*3, ABCB1, and OPRM1 as target genes for detection. The results of statistical analysis showed no significant...
Polymorphism of ABCB1 (062rs1045642) is related to ADRs caused by oxycodone, and the incidence of ADRs is higher with the allele T. Polymorphism of ABCB1 is expected to become a clinical predictor of ...
The effect of systemic hormone therapy (HT) on dementia risk is unclear. Our aim was to investigate the association between HT and dementia....
This register-based study consists of a nested case-control study and a co-twin control design, which controls for familial confounding, including shared genetics....
Through Danish national registries from 1995 to 2011, we identified: a) 2700 female singletons with incident dementia and 13,492 matched controls; b) 288 female twins with incident dementia and co-twi...
The odds ratio (OR) for the association between systemic HT and dementia was 1.05, 95% CI = [0.93-1.19] in singletons and 2.10, 95% CI = [0.99-4.46] in twins. A statistically significant association w...
Using Danish nationwide registries and controlling for education and for familial factors in a subsample, systemic HT was found to be associated with increased dementia risk if used before 2003, when ...